Medtronic (MDT) Appoints Michael Coyle to EVP and Group President of Cardiology Business
Medtronic, Inc. (NYSE: MDT), today announced the appointment of Michael J. Coyle as executive vice president and group president of its Cardiology businesses. Coyle will lead all aspects of the group, which includes the company's Cardiac Rhythm Disease Management (CRDM), CardioVascular and Physio-Control businesses. He will be a member of the Executive Committee and report to Chairman and CEO Bill Hawkins.
Reporting to Coyle will be Pat Mackin, senior vice president and president, CRDM; Scott Ward, senior vice president and president, CardioVascular; and Brian Webster, president, Physio-Control.
Prior to joining Medtronic, Coyle held a number of leadership positions in the medical technology industry, most recently leveraging his broad healthcare industry knowledge and expertise to advise and provide leadership consulting services to private equity, venture capital and medical device firms across the country. He served as president of St. Jude Medical's Cardiac Rhythm Management division from 2001 to 2007, where he led that company's global pacemaker, implantable cardioverter defibrillator and cardiac resynchronization therapy businesses, and from 1997 to 2001, served as president of St. Jude's Daig Catheter division. Prior to St. Jude, he held various leadership positions at Eli Lilly & Company.
Coyle received his master's degree in business administration specializing in finance and marketing from the Wharton School of Business and also holds a chemical engineering degree from Case Western Reserve University.
Create E-mail AlertRelated Categories
Management ChangesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
